American Society of Clinical Oncology GI Cancers Symposium 2027
American Society of Clinical Oncology GI Cancers Symposium 2027 takes place on 21–23 January 2027 at Moscone Center, San Francisco. It is organised by American Society of Clinical Oncology, and B2DB lists 35 speakers and 31 sessions announced so far.
The ASCO Gastrointestinal Cancers Symposium (#GI27) is a multidisciplinary meeting on gastrointestinal cancers, held 21-23 January 2027 at Moscone West in San Francisco. Cosponsored by ASCO, the American Gastroenterological Association, the American Society for Radiation Oncology and the Society of Surgical Oncology, it presents research and practice-focused strategies for translating data into patient outcomes. The 2027 programme is chaired by David Shibata, MD, with Kevan M. Shokat, PhD, as keynote speaker.
Key facts
| Dates | 21–23 January 2027 (upcoming) |
|---|---|
| Venue | Moscone Center, San Francisco, United States of America |
| Organiser | American Society of Clinical Oncology |
| Series | ASCO GI Cancers Symposium |
| Speakers | 35 |
| Sessions | 31 |
| Stages | Cancers of the Esophagus and Stomach, Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract, Cancers of the Colon, Rectum, and Anus |
| Sponsors | 6 |
| Official site | asco.org/gi/program |
Keynote speakers
- Kevan M. Shokat University of California San Francisco
Speakers (35)
Compiled from the published agenda; speakers can claim and verify their own entry.
- Kevan M. Shokat University of California San Francisco
- Jeanne Tie Medical Oncologist, Peter MacCallum Cancer Centre
- Ajay Bansal University of Kansas Medical Center
- Aparajita Singh UCSF Health
- David Binder University of Colorado School of Medicine
- Douglas R. Morgan University of Alabama at Birmingham
- Felice Schnoll-Sussman Weill Cornell Medical College
- Fumiko Chino The University of Texas MD Anderson Cancer Center
- Funda Meric-Bernstam The University of Texas MD Anderson Cancer Center
- Ignacio Garrido-Laguna Moffitt Cancer Center
- Jacquelyne Janean Gaddy Yale Cancer Center
- James L. Gulley Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health
- Jason Samarasena University of California Irvine Medical Center
- Jeneth Aquino Vanderbilt-Ingram Cancer Center
- Johannes Betge University Hospital Mannheim, Heidelberg University
- Julio Garcia-Aguilar Memorial Sloan Kettering Cancer Center
- Junaid Arshad Jackson Memorial Hospital, University of Miami
- Karyn A. Goodman Mount Sinai
- Kevin Waters Cedars-Sinai Medical Center
- Lorenzo Ferri McGill University
- Mark Yarchoan The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Masanori Terashima Shizuoka Cancer Center
- Matthew B. Yurgelun Dana-Farber Cancer Institute
- Mio Kitano Vanderbilt University
- Patrick Alexander Ott Dana-Farber Cancer Institute
- Paul Eliezer Oberstein New York University Langone Health
- Robert Hollis Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
- Salma K. Jabbour Rutgers Cancer Institute
- Stephanie B. Wheeler The University of North Carolina at Chapel Hill
- Stephanie G. Worrell University of Arizona
- Thomas A. Hope University of California San Francisco
- Ugur Selek School of Medicine, Koç University
- Van K. Morris The University of Texas MD Anderson Cancer Center
- Yelena Y. Janjigian Memorial Sloan Kettering Cancer Center
- Zachariah Foda Johns Hopkins University
Most represented companies
- The University of Texas MD Anderson Cancer Center — 3 speakers
- Dana-Farber Cancer Institute — 2 speakers
- Memorial Sloan Kettering Cancer Center — 2 speakers
- University of California San Francisco — 2 speakers
Agenda (31 sessions)
Day 1 — Thursday 21 January 2027
- Oral Abstract Session A: Cancers of the Esophagus and Stomach 08:05–09:45
- De-Escalation Strategies in Upper Gastrointestinal Cancers 10:15–11:30 · Cancers of the Esophagus and Stomach — David Binder, Jason Samarasena, Junaid Arshad, Lorenzo Ferri +1 more
- Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers 11:30–13:00
- Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers 11:30–13:00
- Intersections Session: Novel Therapeutic Approaches in Precision Targeting and Next-Wave Gastrointestinal Therapeutics 13:00–14:15 · Cancers of the Esophagus and Stomach — Funda Meric-Bernstam, Ignacio Garrido-Laguna, Thomas A. Hope
- Addressing the Biomarker Puzzle: Personalized Treatment Paths in Gastric Cancer 14:45–16:00 · Cancers of the Esophagus and Stomach — Johannes Betge, Salma K. Jabbour, Yelena Y. Janjigian
- Breakout Session: To Treat or to Watch—Modern Approach to Surveillance and Management of Precancerous Lesions and Early Upper Gastrointestinal Cancers 14:45–16:00 · Cancers of the Esophagus and Stomach — Douglas R. Morgan, Felice Schnoll-Sussman, Kevin Waters, Masanori Terashima
- Rapid Oral Abstract Session A: Cancers of the Esophagus and Stomach 16:15–17:00
- Trials in Progress Poster Session A (Continued) With Complimentary Wine and Cheese Reception 17:00–18:00
- Poster Session A (Continued) With Complimentary Wine and Cheese Reception 17:00–18:00
Day 2 — Friday 22 January 2027
- Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract 07:40–09:15
- Keynote: From Innovation to Implementation: Navigating the Undruggable KRAS Frontier in Gastrointestinal Cancers 09:30–10:15 · Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract — Kevan M. Shokat
- The Arrival of KRAS Inhibitors for Pancreatic Adenocarcinoma: What Now? 10:45–12:00 · Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract — Paul Eliezer Oberstein, Stephanie B. Wheeler
- Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract 12:00–13:30
- Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract 12:00–13:30
- Intersections Session: The Next Frontier of Gastrointestinal Cancer Vaccines 13:30–14:45 · Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract — James L. Gulley, Mark Yarchoan, Patrick Alexander Ott
- Breakout Session: Multidisciplinary Management of Low-Grade Neuroendocrine Tumors—A Case-Based Review 15:15–16:30 · Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
- Multimodality Management of Hepatobiliary Cancers: Locoregional and Systemic Sequencing Paradigms 15:15–16:30 · Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
- Rapid Oral Abstract Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract 16:45–17:30
- Poster Session B (Continued) With Complimentary Wine and Cheese Reception 17:30–18:30
- Trials in Progress Poster Session B (Continued) With Complimentary Wine and Cheese Reception 17:30–18:30
Day 3 — Saturday 23 January 2027
- Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus 07:00–07:55
- Poster Session C: Cancers of the Colon, Rectum, and Anus 07:00–07:55
- Intersections Session: Next-Generation Surveillance and Response in Gastrointestinal Cancers 07:55–09:15 · Cancers of the Colon, Rectum, and Anus — Jeanne Tie, Fumiko Chino
- Rapid Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus 09:30–10:15
- Breakout Session: Total Neoadjuvant Therapy and Watch-and-Wait in Rectal Cancer: Minimizing Toxicity and Maximizing Quality of Life 10:45–12:00 · Cancers of the Colon, Rectum, and Anus — Jeneth Aquino, Julio Garcia-Aguilar, Mio Kitano, Ugur Selek
- Less Is More: Advances in Treatment De-Escalation for Anal Squamous Cell Carcinoma 10:45–12:00 · Cancers of the Colon, Rectum, and Anus — Jacquelyne Janean Gaddy, Karyn A. Goodman, Van K. Morris
- Poster Session C (Continued) With Complimentary Boxed Lunch 12:00–13:30
- Trials in Progress Poster Session C (Continued) With Complimentary Boxed Lunch 12:00–13:30
- Oral Abstract Session C: Cancers of the Colon, Rectum, and Anus 13:30–15:00
- Changing Landscape of Cancer Interception in Lynch Syndrome 15:15–16:30 · Cancers of the Colon, Rectum, and Anus — Ajay Bansal, Aparajita Singh, Matthew B. Yurgelun, Robert Hollis +1 more
Organisers, sponsors and partners
Organiser (1)
American Society of Clinical Oncology
Sponsors (6)
BioNTech SE · Eisai Inc. · Astellas · AstraZeneca · GSK · Merck
Exhibitors (28)
My Faulty Gene · Memorial Sloan Kettering Cancer Center · Natera · Exact Sciences · Pfizer · Bayer · Sanofi · Takeda · BillionToOne · Boehringer Ingelheim · BioNTech SE · Camurus · Jazz Pharmaceuticals · Jacqueline Rush Foundation · Eisai Inc. · Eli Lilly and Company · Astellas · AstraZeneca · Novartis · AbbVie · Daiichi Sankyo · Taiho Oncology, Inc. · BeOne Medicines · Incyte · Boston Scientific · Bristol Myers Squibb · GSK · Myriad Genetics
Source: the published agenda. See how B2DB compiles its records.